3 Companies Rising on News for Friday 10th March 2023
Episode 1251, Mar 10, 2023, 01:23 PM
3 Companies Rising on News for Friday 10th March 2023
1. FIRSTGROUP #FGP - Trading Update
FirstGroup plc today reports an update on trading since the half-year results for the 26 weeks to 24 September 2022, published in November 2022.
The Group anticipates that the FY 2023 Group adjusted operating profit and Group adjusted attributable profit will be ahead of the Group's previous expectations. The Group's expectations for FY 2024 remain unchanged.
The Group expects to report its results for the year ended 25 March 2023 on 8 June 2023.
2. IXICO #IXI - Contract Win
IXICO announces that it has been selected by a biotech company and new client, to provide MRI imaging services for patient selection and efficacy analysis in patients with a rare form of dementia.
The trial deploys an innovative gene therapy approach and is expected to last for just over four years.
3. Tintra #TNT - Strategic investment under current funding round
The board of directors of Tintra confirm that, further to the Company's announcement of 30 November 2022, it has entered into a new subscription agreement (under the current funding round) for US$2,000,000.
The Subscription will be made through a new special purpose vehicle which is being established by the Gulf-based investor for the purpose of making the investment. The Subscription has no conditionality, however based on earlier funding rounds taking longer to close than anticipated, the funds due under the Subscription are, under the agreement entered into between the Company and the investor, contracted to be received within 45 days to enable the establishment of the SPV.
1. FIRSTGROUP #FGP - Trading Update
FirstGroup plc today reports an update on trading since the half-year results for the 26 weeks to 24 September 2022, published in November 2022.
The Group anticipates that the FY 2023 Group adjusted operating profit and Group adjusted attributable profit will be ahead of the Group's previous expectations. The Group's expectations for FY 2024 remain unchanged.
The Group expects to report its results for the year ended 25 March 2023 on 8 June 2023.
2. IXICO #IXI - Contract Win
IXICO announces that it has been selected by a biotech company and new client, to provide MRI imaging services for patient selection and efficacy analysis in patients with a rare form of dementia.
The trial deploys an innovative gene therapy approach and is expected to last for just over four years.
3. Tintra #TNT - Strategic investment under current funding round
The board of directors of Tintra confirm that, further to the Company's announcement of 30 November 2022, it has entered into a new subscription agreement (under the current funding round) for US$2,000,000.
The Subscription will be made through a new special purpose vehicle which is being established by the Gulf-based investor for the purpose of making the investment. The Subscription has no conditionality, however based on earlier funding rounds taking longer to close than anticipated, the funds due under the Subscription are, under the agreement entered into between the Company and the investor, contracted to be received within 45 days to enable the establishment of the SPV.